Erste Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Erste Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-22,300	Closed	-$559K	–	430
2019 Q4	$559K	Hold	22,300	–	–	0.02%	323
2019 Q3	$598K	Hold	22,300	–	–	0.03%	310
2019 Q2	$595K	Buy	+22,300	New	+$699K	0.03%	298
2019 Q1	–	Sell	-22,150	Closed	-$359K	–	449
2018 Q4	$359K	Buy	+22,150	New	+$456K	0.02%	332

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Erste Asset Management's PTLA Position: Q1 2020 in Review

Erste Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 22,300 shares — an estimated $559K sold.

Erste Asset Management first reported a position in PTLA in Q4 2018 and held it in 4 quarters. The position peaked at $598K in Q3 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Erste Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Erste Asset Management sold 22,300 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $559K.
Erste Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2018 and held it in 4 quarters.
Erste Asset Management's Portola Pharmaceuticals, Inc. position peaked at $598K in Q3 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Erste Asset Management's 13F filing for Q1 2020, filed 22 Nov 2024.